STING1 and neoplasm: STING activation promotes the secretion of chemokines, such as CXCL9, CXCL10, and C-C motif chemokine ligand 5 (CCL5), establishing a chemical gradient that guides cytotoxic T lymphocytes (CTLs) into tumor tissue.